EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma

Mariona Morell-Daniel iD, Santiago Pérez-Hoyos iD, Aroa Soriano iD, Ana Coma iD, Amalia Varo, Raquel Hladun, Gabriela Guillén iD, Soraya Mico iD, Marta Garrido iD, Lourdes Rubio, Alba Rubio-San-Simón iD, Ana Minguez und 4 weitere

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Mariona Morell-Daniel und 15 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Oncology and Haematology Department, Hospital Vall d'Hebron, Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS…. Hauptthemen laut MEDLINE: Neuroblastoma, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Asociación Neuroblastoma por Leire, Fundación Neuroblastoma, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While the presence of metastases in neuroblastoma (NB) is a well‐established prognostic factor, the clinical significance of dissemination patterns and tumour burden and their impact on response and survival remains poorly understood.

Objectives

To characterise metastatic dissemination patterns and tumour burden in NB, evaluate their response to induction therapy, and determine their prognostic impact.

Methods

We retrospectively analysed 53 patients with metastatic NB between 2010 and 2024 in a reference tertiary care hospital and treated as per SIOPEN protocol or standard‐of‐care recommendations. Responses were recorded as per INRC 2017. Survival was estimated using Kaplan–Meier analysis, and associations between metastatic patterns and outcomes were evaluated by univariate analysis.

Results

The most frequent metastatic sites were bone (77%), regional lymph nodes (64%), and bone marrow (55%). MSI (metastatic site index) was 1 ( n = 13), 2 ( n = 13), 3 ( n = 15), or ≥4 ( n = 12). Overall response according to INRC after induction therapy achieved complete ( n = 1), partial ( n = 41), minor ( n = 6) responses, stable ( n = 4) or progressive disease ( n = 1). Regarding metastatic response, regional and distant lymph nodes, renal and pulmonary decreased in size by 66%, 85%, 90 and 99%, respectively. The median SIOPEN score decreased from 16.5 to 0. Bone marrow infiltration disappeared in 82%. High tumour burden strongly correlated with poor outcomes.

Conclusions

Presence of renal metastases, ascites, bone marrow infiltration, high tumour burden at diagnosis and post‐induction pulmonary or renal metastases are negative prognostic markers. Incorporating these factors into risk stratification may guide personalised treatment strategies. Future work should elucidate the genomic background and underlying causes of these different metastatic patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleRetrospective StudiesMaleChild, PreschoolInfantPrognosisSurvival RateChildFollow-Up StudiesLymphatic MetastasisNeoplasm Metastasis

Stichwörter der Autor:innen

neoplasmneoplasm metastasisneuroblastomapaediatrics

Autor:innen und Institutionen

  • Paediatric Oncology and Haematology Department, Hospital Vall d'Hebron, Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Barcelona, Spain.
  • Childhood Cancer & Blood Disorders Group, Vall d'Hebron Research Institute, Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Barcelona, Spain.
  • Departamento de Medicina, Universidad Autónoma de Barcelona, Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Barcelona, Spain.
  • Genetics, Microbiology and Statistics Department, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
  • Paediatric Radiology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain.
  • Paediatric Surgery Department, Vall d'Hebron Hospital Campus, Barcelona, Spain.

ORCID-Profile: Mariona Morell-Daniel, Santiago Pérez-Hoyos, Aroa Soriano, Ana Coma, Gabriela Guillén, Soraya Mico, Marta Garrido, Alba Rubio-San-Simón, Ricardo López-Almaraz, Miguel F Segura, Lucas Moreno

Förderung

  • Asociación Neuroblastoma por Leire
  • Fundación Neuroblastoma
  • Instituto de Salud Carlos III

Zitieren

APA

Morell-Daniel, M., Pérez-Hoyos, S., Soriano, A., Coma, A., Varo, A., Hladun, R., Guillén, G., Mico, S., Garrido, M., Rubio, L., Rubio-San-Simón, A., Minguez, A., López-Almaraz, R., Illade, L., Segura, M. F., & Moreno, L. (2026). Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70558

Vancouver

Morell-Daniel M, Pérez-Hoyos S, Soriano A, Coma A, Varo A, Hladun R, et al. Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70558

BibTeX
@article{MorellDaniel2026,
  author = {Morell-Daniel, Mariona and Pérez-Hoyos, Santiago and Soriano, Aroa and Coma, Ana and Varo, Amalia and Hladun, Raquel and Guillén, Gabriela and Mico, Soraya and Garrido, Marta and Rubio, Lourdes and Rubio-San-Simón, Alba and Minguez, Ana and López-Almaraz, Ricardo and Illade, Laura and Segura, Miguel F and Moreno, Lucas},
  title = {Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70558}
}
Kostenlos starten →